ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 289074 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 289074; 2) Community: the network communities that were significantly associated with the response to NSC 289074; 3) Molecule: the relationships between components within communities and NSC 289074; 4) MDR: the compounds that were significantly associated with the NSC 289074.

NSC Compound Enrichment Correlation
NSC 762149 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide 0.0312262198176281 -0.22426079
NSC 92915 ANTINEOPLASTIC-92915 0.0312262198176281 0.70513547
NSC 244714 Benzoic acid, 3,5-dinitro-2-(1H-purin-6-ylthio)-, ethyl ester 0.0312262198176283 0.66475377
NSC 250682 Oridonin 0.0312262198176283 0.63309896
NSC 303861 L-Cysteine analog 0.0352383000003058 0.43669918
NSC 30915 Null 0.0352383000003058 0.62707654
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0352383000003058 0.68043439
NSC 409749 Null 0.0352383000003058 0.36494522
NSC 633514 Null 0.0352383000003058 0.38664483
NSC 637505 Null 0.0352383000003058 0.19460681
Total:70  Current:52    [First] [Prev] [Next] [Last]